Danaher Diagnostics — Depreciation increased by 5.0% to $106.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.9%, from $102.00M to $106.00M. Over 2 years (FY 2023 to FY 2025), Diagnostics — Depreciation shows relatively stable performance with a 3.6% CAGR.
An increase often reflects higher investment in physical infrastructure, while a decrease may suggest aging assets or reduced capital intensity.
The systematic allocation of the cost of tangible fixed assets, such as manufacturing equipment and laboratory facilitie...
Commonly reported as part of segment-level operating expenses across industrial and manufacturing firms.
dhr_segment_diagnostics_depreciation| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $94.75M | $94.75M | $94.75M | $94.75M | $97.00M | $100.00M | $95.00M | $102.00M | $100.00M | $100.00M | $101.00M | $106.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.4% | +3.1% | -5.0% | +7.4% | -2.0% | +0.0% | +1.0% | +5.0% |
| YoY Change | — | — | — | — | +2.4% | +5.5% | +0.3% | +7.7% | +3.1% | +0.0% | +6.3% | +3.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.